Structure-dependent stimulation of gut bacteria by arabinoxylo-oligosaccharides (AXOS): a review.

Autor: Leschonski KP; National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.; Novonesis A/S, Kongens Lyngby, Denmark., Mortensen MS; National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark., Hansen LBS; Novonesis A/S, Kongens Lyngby, Denmark., Krogh KBRM; Novonesis A/S, Kongens Lyngby, Denmark., Kabel MA; Laboratory of Food Chemistry, Wageningen University, Wageningen, The Netherlands., Laursen MF; National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.
Jazyk: angličtina
Zdroj: Gut microbes [Gut Microbes] 2024 Jan-Dec; Vol. 16 (1), pp. 2430419. Date of Electronic Publication: 2024 Nov 29.
DOI: 10.1080/19490976.2024.2430419
Abstrakt: Arabinoxylo-oligosaccharides (AXOS) are non-digestible dietary fibers that potentially confer a health benefit by stimulating beneficial bacteria in the gut. Still, a detailed overview of the diversity of gut bacteria and their specificity to utilize structurally different AXOS has not been provided to date and was aimed for in this study. Moreover, we assessed the genetic information of summarized bacteria, and we extracted genes expected to encode for enzymes that are involved in AXOS hydrolysis (based on the CAZy database). The taxa involved in AXOS fermentation in the gut display a large variety of AXOS-active enzymes in their genome and consequently utilize AXOS to a highly different extent. Clostridia and Bacteroidales are generalists that consume many structurally diverse AXOS, whereas Bifidobacterium are specialists that specifically consume AXOS with a low degree of polymerization. Further complexity is evident from the fact that the exact bacterial species, and in some cases even the bacterial strains (e.g. in Bifidobacterium longum ) that are stimulated, highly depend on the specific AXOS molecular structure. Furthermore, certain species in Bifidobacterium and Lactobacillaceae are active as cross-feeders and consume monosaccharides and unbranched short xylo-oligosaccharides released from AXOS. Our review highlights the possibility that (enzymatic) fine-tuning of specific AXOS structures leads to improved precision in targeting growth of specific beneficial bacterial species and strains in the gut.
Databáze: MEDLINE